Literature DB >> 8581496

Beta-amyloid (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat.

T Harkany1, G I De Jong, K Soós, B Penke, P G Luiten, K Gulya.   

Abstract

beta-Amyloid(1-42) peptide (beta AP(1-42) was injected into the medial septum of rats. After a 14-day survival time, neuronal alterations in the septal cholinergic and GABAergic systems were visualized by means of histo- and immunocytochemical methods. Neurons insulted by the peptide were primary choline acetyltransferase-immunoreactive (ir), while only minor effects of beta AP(1-42) were observed on parvalbumin-ir interneurons. These results indicate that the changes in intracellular Ca2+ level elicited by beta AP(1-42) may contribute to beta-amyloid neurotoxicity, and Ca(2+)-binding proteins may play an important role in the protection against the neurotoxic effects of beta AP(1-42).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581496     DOI: 10.1016/0006-8993(95)01013-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice.

Authors:  M Popović; M Caballero-Bleda; I Kadish; T Van Groen
Journal:  Neuroscience       Date:  2008-05-24       Impact factor: 3.590

2.  Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.

Authors:  Michel J Grothe; Michael Ewers; Bernd Krause; Helmut Heinsen; Stefan J Teipel
Journal:  Alzheimers Dement       Date:  2014-01-10       Impact factor: 21.566

3.  Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease.

Authors:  Masanori Itakura; Hidemitsu Nakajima; Takeya Kubo; Yuko Semi; Satoshi Kume; Shusaku Higashida; Akihiro Kaneshige; Mitsuru Kuwamura; Naoki Harada; Akinori Kita; Yasu-Taka Azuma; Ryoichi Yamaji; Takashi Inui; Tadayoshi Takeuchi
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

4.  Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron.

Authors:  T A Good; R M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 5.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

6.  Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

Authors:  W A Pedersen; M A Kloczewiak; J K Blusztajn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function.

Authors:  Luis V Colom; Maria T Castañeda; Cristina Bañuelos; Gustavo Puras; Antonio García-Hernández; Sofia Hernandez; Suzanne Mounsey; Joy Benavidez; Claudia Lehker
Journal:  Neurobiol Aging       Date:  2008-06-10       Impact factor: 4.673

8.  Intracerebroventricular Aβ-Induced Neuroinflammation Alters Peripheral Immune Responses in Rats.

Authors:  Pritha Gupta; Susmita Sil; Rupsa Ghosh; Arijit Ghosh; Tusharkanti Ghosh
Journal:  J Mol Neurosci       Date:  2018-10-31       Impact factor: 3.444

Review 9.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

10.  Altered theta rhythm and hippocampal-cortical interactions underlie working memory deficits in a hyperglycemia risk factor model of Alzheimer's disease.

Authors:  Ryan A Wirt; Lauren A Crew; Andrew A Ortiz; Adam M McNeela; Emmanuel Flores; Jefferson W Kinney; James M Hyman
Journal:  Commun Biol       Date:  2021-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.